Microbot Medical (NASDAQ:MBOT – Get Free Report) is projected to post its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter.
Microbot Medical Price Performance
Shares of NASDAQ MBOT opened at $1.60 on Tuesday. Microbot Medical has a 1-year low of $0.82 and a 1-year high of $3.38. The business’s 50 day moving average is $1.75 and its two-hundred day moving average is $1.30. The stock has a market capitalization of $55.59 million, a P/E ratio of -2.00 and a beta of 1.60.
Analyst Ratings Changes
Separately, HC Wainwright boosted their target price on Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a research report on Friday, January 24th.
About Microbot Medical
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Read More
- Five stocks we like better than Microbot Medical
- 3 Stocks to Consider Buying in October
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Roth IRA Calculator: Calculate Your Potential Returns
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Low PE Growth Stocks: Unlocking Investment Opportunities
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.
